April 14, 2014 Congratulations to Levi Garraway and Rakesh Jain, who were among the 2014 American Association for Cancer Research (AACR) awardees: Levi Garraway (DFCI) was... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- Seminars in Oncology: "The Role of the Tumor Microenvironment in Breast Cancer Progression" Posted: 04-23-14
- The DF/HCC Collaborative RNAi Core adds support for genome engineering Posted: 04-23-14
- Seminars in Oncology: "Arginine Methylation - Substrates, Binders and Function" Posted: 04-16-14
Latest Cancer News
April 2014 | eNews The TPETT program, with its mission to facilitate the development of new anticancer agents from the preclinical to the clinical stages, relies on basic... | [more]
April 2014 | eNews As researchers delve ever deeper into the underpinnings of cancer biology, more therapeutic targets emerge; targets that, when attacked, will in theory... | [more]